Jahr: 2020

joimax® Announces Partnership with Southeast Asia Distributor, Transmedic Group

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore. In this exclusive deal, Transmedic will represent joimax® in Singapore, Hong Kong, Philippines and Indonesia. 

The long-term partnership will provide a broader surgical choice for patients considering endoscopic minimally invasive spinal surgery in these markets. With recent advances in the field of endoscopic discectomy (ED), the procedure has potential to supersedemicrodiscectomy (MD) as the gold standard of care in management of lumbar disc disease, as the latest literature suggests. 

“joimax® is very much looking forward to working with Transmedic Group,” says joimax® Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.” 

Teo Kee Meng, managing director of Transmedic Group commented, “We’re very pleased to partner with joimax®. With their technological advancements and use of new spinal access corridors, a major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times.”

About Transmedic Group
Transmedic Group was founded in 1980 with the aim of becoming the top specialist in the advanced medical technology area in Southeast Asia. Headquartered in Singapore, the privately held company has since grown its presence in seven countries with more than 500 employees, and is well-renowned as the leading provider of latest technologies in healthcare.

FDA Approves joimax® Intracs®em Electromagnetic Navigation System for Endoscopic Minimally Invasive Spine Surgery

Veröffentlicht am von christine.stump@joimax.com

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce that Intracs® em, its electromagnetic navigation tracking and control system, has been approved by the FDA.

The Intracs® em Navigation System allows for spinal procedures to be carried out with minimal X-ray control, drastically reducing radiation exposure, access time, and the entire length of the surgical procedure. In fact, all joimax® instruments and scopes can be tracked and accurately navigated through the appropriate sensors, which improves safety, expands endoscopic indications, and flattens the learning curve.

Intracs®em is a multiyear development. Its first cadaveric trials were made with a group of surgeons at the ESPINEA® Labs in Karlsruhe, Germany and Irvine, CA.

According to Prof. Dr. med. Michael Kraus of ORTHIX Zentrum in Augsburg, Germany, who headed the preliminary trials: “Using Intracs® em Navigation System in the full endoscopic spine surgery is safe and easily applicable. The technology helps master precise access to the spine, and the clinical trials have confirmed the technique’s multiple advantages.”

Prof. Dr. Chris Hofstetter of UW Medical Center in Seattle, Washington, USA, adds: “joimax® Intracs®em constitutes a highly precise image-guided navigation platform designed for the specific needs of full-endoscopic spine surgery. Using electromagnetic navigation technology allows to track the leading edge of endoscopic instruments in real time, and facilitates needle targeting and orientation during the surgery, while minimizing radiation exposure. No doubt, this technology will expand the indications for full-endoscopic spine surgery and pave the way for innovations in minimally invasive arthrodesis techniques.”

joimax® is also excited to announce its second joint Global Symposium being held in partnership with Integrity Implants, Inc., August 21 – 22. For details, visit www.joimax.com.

joimax® Expands Presence in Australia

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Australian medical device distributor, LifeHealthcare. The two companies have entered into a long-term relationship to provide a broader surgical choice for patients considering spinal surgery.

“We’re looking forward to working with a partner as strong as LifeHealthcare,” says joimax® Founder and CEO Wolfgang Ries. “LifeHealthcare shares our goals and vision, ensuring that we are able to deliver the highest standards of patient care.”

Endoscopic spine surgery has been steadily growing in popularity since the late 1990’s with exponential growth in the technique for the past ten years. Surgeons throughout the world have reported that this type of surgery can assist patients in faster recovery, enabling them to reduce their post-operative stay.

“We’re very pleased to collaborate with joimax®,” comments LifeHealthcare Chief Executive Officer Matt Muscio. “Endoscopic spine surgery is a technique that enables patients to have access to truly minimally invasive surgical procedures of the spine.”

Thus, joimax® strengthens its sales activities in Australia and enters into another important partnership across APAC.

About LifeHealthcare

LifeHealthcare is a leading independent provider of healthcare solutions in Australia and New Zealand bringing healthcare professionals innovative medical devices by partnering with world class companies who share the vision of innovation and making a real difference to people’s lives. LifeHealthcare has been recognised as one of the Financial Times 1,000 High Growth Companies in Asia-Pacific. In May 2018, LifeHealthcare was acquired by Australia’s largest private equity fund, Pacific Equity Partners, a market leader that has been recognised as a Top 20 Consistent Performer Globally by Prequin. For further information, please visit www.lifehealthcare.com.au.

joimax® Signs National Distribution Partner in Taiwan

Veröffentlicht am von christine.stump@joimax.com

(Karlsruhe-GER, 26 June 2020)
Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide distributor in Taiwan, Hi-Clearance Inc. With the aim of building an effective, long-term relationship, the strategic supplier partnership is a further milestone in the international growth of joimax® .

“Hi-Clearance is our ideal sales and service partner,” says joimax® CEO and Founder Mr. Wolfgang Ries. With their streamlined structure and process in place, we are confident joimax® will penetrate this new market very successfully”.

Hi-Clearance Inc. has over 239 employees, and is a well-known supplier of medical materials and equipment in Taiwan. “We are very pleased about the new strategic partnership and are excited to continue the strong growth of both companies,” states Hi-Clearance Chairman Mr. John Lee and President Mr. Ernie Chen. “We are dedicated to establishing joimax® as the leading brand of endoscopic spine surgery in Taiwan.”

Hi-Clearance Inc. is headquartered in Taipei with four other branches spread across the country. The main business includes products for Hemodialysis, Critical Care, Dental, Cardiology, Homecare Devices, Nutrition and a major Spine Surgery Division. In 2019, sales were USD 107 million.

New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

Veröffentlicht am von christine.stump@joimax.com

(Karlsruhe-GER, 16 June 2020)

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

“joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

joimax® Organizes its First Online Endoscopic Spine Symposium

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe (GER) — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online global symposium, “Endoscopic Spine Surgery – Indications, Technology and Limitations”, at its headquarters in the Training and Education Center (TEC) in Karlsruhe-Germany, on April 24-25, 2020.

In view of the coronavirus restrictions introduced by many governments, in March,  joimax® began holding weekly webinars, in partnership with key surgeons, to demonstrate the latest endoscopic techniques. The training sessions culminated with a two-day Symposium, full of live discussions and video demonstrations, scheduled during Western and Eastern time zones.

On April 24, joimax® Founder and CEO Wolfgang Ries, moderated a panel with faculty members Ralf Wagner, MD (Ligamenta Spine Center Frankfurt-Germany) and Christoph Hofstetter, MD, PhD (University of Washington Medicine, Neurosurgery Department, Seattle/USA). The following day, faculty member, Junseok Bae, MD (President of Wooridul Spine Hospital Seoul, South Korea), joined the panel.

On both days, the agenda included a theoretical part focused on transforaminal and interlaminar indications, and the general possibilities of endoscopy from lumbar to thoracic to cervical, as well as a hands-on lab portion. In the wet lab, Dr. Ralf Wagner demonstrated the joimax® product application of TESSYS® and iLESSYS® in specific indications. Moreover, there were presentations of Intracs® em , the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip. This navigation system combines lateral and AP images of the C-arm with CT scan, providing surgeons with most accurate views of the target region.

The Symposium also featured special guests: Dr. Menno Iprenburg (Iprenburg Spine Clinic, Veenhuizen, Netherlands) and Prof. Alastair Gibson (The Royal Infirmary of Edinburgh, Edinburgh Scotland); both board members of ESPINEA® Academy, who gave their valued input, based on their long-lasting experience.

“This is the  future of digital education and a great way to virtually meet and learn,” stated Dr. Iprenburg.  Prof. Gibson added, “excellent Symposium; it couldn’t get any better”.

The Symposium marked a major milestone, with 430 participants. Surgeons from all over the world joined this unique online education program and stimulating Q&A session.

When safe, joimax® will transition back to on-site workshops and trainings, but in the  meantimewill continue with its attention-grabbing online webinars.